Shares of Lattice Semiconductor Corp (NASDAQ: LSCC) recovered slightly in early trading on Tuesday, after the company reported mixed results for the four
Insights from Wedbush analysts about the clinical effectiveness of REGENXBIO's RGX-202, market potential, and challenges posed by competitors like Sarepta Therapeutics and Pfizer.
Rocket Lab (NASDAQ: RKLB) stock rose 8% after being reinstated by Citigroup analyst with $6 price target. Recent transactions and US govt award boost outlook.
Parikh maintains Outperform rating on WMT, raises price target to $185. Bull case still in early to middle innings, potential for continued outperformance. Optimistic about PhonePe and Flipkart IPO unlocking more value. WMT remains top pick, shares up 8% YTD.
"Bausch + Lomb's Q4 & FY 2023 results on Feb 21, 2024. Expecting $1.107 billion in sales, $0.17 EPS. RBC Capital predicts $1.159 billion revenue. Insights on Miebo launch and enhanced EBITDA margins for 2024.